Rising Biosciences (Rising Biosciences) Total Assets : $0.00 Mil (As of . 20)

View and export this data going back to . Start your Free Trial

What is Rising Biosciences Total Assets?

Rising Biosciences's Total Assets for the quarter that ended in . 20 was $0.00 Mil.

Total Assets is connected with ROA %. Rising Biosciences's annualized ROA % for the quarter that ended in . 20 was %. Total Assets is also linked to Revenue through Asset Turnover. Rising Biosciences's Asset Turnover for the quarter that ended in . 20 was .

Rising Biosciences Total Assets Historical Data

The historical data trend for Rising Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Total Assets Chart

Rising Biosciences Annual Data

Trend

Total Assets

Rising Biosciences Quarterly Data

Total Assets

Rising Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Rising Biosciences's Total Assets for the fiscal year that ended in . 20 is calculated as

Total Assets	=	Total Equity (A: . 20 )	+	Total Liabilities (A: . 20 )
	=	N/A	+	N/A
	=	N/A

Rising Biosciences's Total Assets for the quarter that ended in . 20 is calculated as

Total Assets	=	Total Equity (Q: . 20 )	+	Total Liabilities (Q: . 20 )
	=	N/A	+	N/A
	=	N/A

Rising Biosciences (GREY:RBII) Total Assets Explanation

Total Assets is connected with ROA %.

Rising Biosciences's annualized ROA % for the quarter that ended in . 20 is

ROA %	=	Net Income (Q: . 20 )	/	( (Total Assets (Q: . 20 )	+	Total Assets (Q: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

Note: The Net Income data used here is four times the quarterly (. 20) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Rising Biosciences's Asset Turnover for the quarter that ended in . 20 is

	Asset Turnover
=	Revenue (Q: . 20 )	/	( (Total Assets (Q: . 20 )	+	Total Assets (Q: . 20 ))	/ count )
=		/	( (	+	)	/ )
=		/
=

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Rising Biosciences Total Assets Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Rising Biosciences (Rising Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

1180 Cleveland Road, Sandusky, OH, USA, 44870

Website

http://www.risingbiosciences.com

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.